Table 1 Clinical characteristics of all participants.

From: Evaluation of bone fragility in cognitively or physically impaired elderly care home patients using radiofrequency echographic multi-spectrometry

 

All participants (N = 260)

Sex, Male : Female

39 : 221

Mean age, years

82.29 (6.69)

Weight, kg

49.97 (9.00)

Height, cm

148.67 (8.54)

Body mass index, kg/m2

22.67 (4.03)

Present illness

 

 RA

9 (3.5%)

 DM

20 (7.7%)

 CKD

26 (10.0%)

 Malignant tumor

34 (13.1%)

Medication

 

 GC

12 (4.6%)

 Daily dose, mg

4.58 (2.78)

 Sleeping pills

71 (27.3%)

 Antidepressant

10 (3.8%)

 Warfarin

9 (3.5%)

 Methotrexate

3 (1.2%)

 Osteoporosis treatment

167 (64.2%)

 BP

49 (29.3%)

 DMAb

54 (32.3%)

 PTH

3 (1.8%)

 SERM

21 (12.6%)

 ROMO

8 (4.8%)

 VD alone

6 (3.6%)

 Smoking

22 (8.5%)

 Drinking

36 (13.8%)

 History of fragility fractures

117 (45.0%)

  1. Data presented as average (standard deviation of the mean) and number of cases (percentage).
  2. RA: rheumatoid arthritis; DM: diabetes mellitus; CKD: chronic kidney disease; GC: glucocorticoids; BP: bisphosphonate; DMAb: denosumab; PTH: parathyroid hormone; SERM: Selective Estrogen Receptor Modulator; ROMO: romosozumab; VD: vitamin D3 preparation.
Back to article page